These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 10643226

  • 1. [Combination treatment with insulin and metformin in type 2 diabetes. Improves glycemic control and prevents weight gain].
    Hermann LS, Melander A.
    Lakartidningen; 1999 Dec 15; 96(50):5616-9. PubMed ID: 10643226
    [Abstract] [Full Text] [Related]

  • 2. Continuing metformin when starting insulin in patients with Type 2 diabetes: a double-blind randomized placebo-controlled trial.
    Douek IF, Allen SE, Ewings P, Gale EA, Bingley PJ, Metformin Trial Group.
    Diabet Med; 2005 May 15; 22(5):634-40. PubMed ID: 15842521
    [Abstract] [Full Text] [Related]

  • 3. Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes.
    Raskin P.
    Diabetes Obes Metab; 2008 Dec 15; 10(12):1167-77. PubMed ID: 18494804
    [Abstract] [Full Text] [Related]

  • 4. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
    De Jager J, Kooy A, Lehert P, Bets D, Wulffelé MG, Teerlink T, Scheffer PG, Schalkwijk CG, Donker AJ, Stehouwer CD.
    J Intern Med; 2005 Jan 15; 257(1):100-9. PubMed ID: 15606381
    [Abstract] [Full Text] [Related]

  • 5. Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.
    Ponssen HH, Elte JW, Lehert P, Schouten JP, Bets D.
    Clin Ther; 2000 Jun 15; 22(6):709-18. PubMed ID: 10929918
    [Abstract] [Full Text] [Related]

  • 6. Sitagliptin: a novel drug for the treatment of type 2 diabetes.
    Choy M, Lam S.
    Cardiol Rev; 2007 Jun 15; 15(5):264-71. PubMed ID: 17700385
    [Abstract] [Full Text] [Related]

  • 7. Discontinuation of metformin in type 2 diabetes patients treated with insulin.
    Wulffelé MG, Kooy A, Lehert P, Bets D, Oom JA, Borger van der Burg B, Donker AJ, Stehouwer CD.
    Neth J Med; 2002 Jul 15; 60(6):249-52. PubMed ID: 12365468
    [Abstract] [Full Text] [Related]

  • 8. Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes.
    Brazg R, Xu L, Dalla Man C, Cobelli C, Thomas K, Stein PP.
    Diabetes Obes Metab; 2007 Mar 15; 9(2):186-93. PubMed ID: 17300594
    [Abstract] [Full Text] [Related]

  • 9. Promising new approaches.
    Reasner CA.
    Diabetes Obes Metab; 1999 May 15; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [Abstract] [Full Text] [Related]

  • 10. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G, Maffioli P, Salvadeo SA, Ferrari I, Gravina A, Mereu R, Palumbo I, D'Angelo A, Cicero AF.
    Metabolism; 2009 Aug 15; 58(8):1059-66. PubMed ID: 19394976
    [Abstract] [Full Text] [Related]

  • 11. Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
    Massi-Benedetti M, Orsini-Federici M.
    Diabetes Care; 2008 Feb 15; 31 Suppl 2():S131-5. PubMed ID: 18227473
    [Abstract] [Full Text] [Related]

  • 12. Weight gain during insulin therapy in patients with type 2 diabetes mellitus.
    Heller S.
    Diabetes Res Clin Pract; 2004 Sep 15; 65 Suppl 1():S23-7. PubMed ID: 15315867
    [Abstract] [Full Text] [Related]

  • 13. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
    Yki-Järvinen H.
    Diabetes Metab Res Rev; 2002 Sep 15; 18 Suppl 3():S77-81. PubMed ID: 12324990
    [Abstract] [Full Text] [Related]

  • 14. [Metformin. Mode of action and effect of monotherapy and combination therapy on glucose metabolism in type 2 diabetes].
    Christiansen AL, Madsbad S.
    Ugeskr Laeger; 2002 Apr 08; 164(15):2025-8. PubMed ID: 11985000
    [Abstract] [Full Text] [Related]

  • 15. Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus.
    Strowig SM, Raskin P.
    Diabetes Obes Metab; 2005 Nov 08; 7(6):633-41. PubMed ID: 16219007
    [Abstract] [Full Text] [Related]

  • 16. New oral therapies for type 2 diabetes.
    Purnell JQ, Hirsch IB.
    Am Fam Physician; 1997 Nov 01; 56(7):1835-42. PubMed ID: 9371013
    [Abstract] [Full Text] [Related]

  • 17. Diabetes control without weight gain.
    Health News; 1999 Apr 15; 5(5):6. PubMed ID: 10214130
    [No Abstract] [Full Text] [Related]

  • 18. [Combination therapy of oral antidiabetic drugs with insulin].
    Lotz N, Bachmann W.
    Z Gesamte Inn Med; 1993 Mar 15; 48(3):130-4. PubMed ID: 8475636
    [Abstract] [Full Text] [Related]

  • 19. [Insulin sparing and metabolic control with metformin-insulin combination].
    Isnard F.
    Journ Annu Diabetol Hotel Dieu; 1997 Mar 15; ():305-25. PubMed ID: 9296986
    [No Abstract] [Full Text] [Related]

  • 20. [Capabilities of hypoglycemic therapy in women with decompensated type 2 diabetes mellitus].
    Onuchin SG, Elsukova OS, Solov'ev OV, Onuchina EL.
    Ter Arkh; 2010 Mar 15; 82(8):34-41. PubMed ID: 20873243
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.